Business News

Business

Rupee Plunges to Historic Low: 6th Consecutive Day at 85.2/$

The Indian rupee hit an all-time low for the sixth consecutive trading session, closing at 85.20 against the US dollar. Factors contributing to the decline include rising US bond y...

Business

India's Insurance Penetration Dips: A Closer Look at the Numbers

India's insurance penetration has declined for the second year in a row, reaching 3.7% in FY24. This contrasts with global trends of increasing insurance penetration, highlighting ...

Business

Lyft Sues San Francisco Over Alleged $100 Million Tax Overcharge

Lyft Inc. has launched a legal battle against San Francisco, accusing the city of improperly levying $100 million in taxes over the past five years. The lawsuit claims that San Fra...

Business

Toyota Joins Inauguration Donations, Announces Merger Talks with Honda

Toyota donates $1 million for Trump's inauguration and announces merger talks with Honda, following Ford's similar donation and tech giants' contributions.

Business

UltraTech Cement Acquires India Cements, Strengthening Market Dominance

UltraTech Cement has acquired India Cements, making it a subsidiary and integrating its 14.5 million tonnes capacity into UltraTech's 155 MTPA. This move strengthens UltraTech's ma...

Business

OpenAI Explores Humanoid Robot Development, But Focus Remains on AI Models

OpenAI is reportedly considering developing a humanoid robot, but its main focus remains on enhancing AI models and creating AI agents for software engineering and data analysis au...

Business

Razorpay Extends Rs 1 Lakh ESOPs to All 3,000 Employees

Razorpay announced it is extending employee stock options worth Rs 1 lakh to each of its over 3,000 staffers, reflecting the company's commitment to an employee-first ethos.

Business

AstraZeneca's EU Lung Cancer Drug Application Withdrawn Amid Mixed Trial Results

AstraZeneca and Daiichi Sankyo withdraw their EU marketing authorization application for datopotamab deruxtecan due to mixed trial results, but remain committed to ongoing research...